Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Will children reveal their secret? The coronavirus dilemma
Luca Cristiani, Enrica Mancino, Luigi Matera, et al.
European Respiratory Journal (2020) Vol. 55, Iss. 4, pp. 2000749-2000749
Open Access | Times Cited: 191

Showing 1-25 of 191 citing articles:

Age-Related Morbidity and Mortality among Patients with COVID-19
Seung‐Ji Kang, Sook‐In Jung
Infection and Chemotherapy (2020) Vol. 52, Iss. 2, pp. 154-154
Open Access | Times Cited: 504
Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation
Mary Hongying Cheng, She Zhang, Rebecca A. Porritt, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 41, pp. 25254-25262
Open Access | Times Cited: 320
Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option?
Konstantinos Farsalinos, Anastasia Barbouni, Raymond Niaura
Internal and Emergency Medicine (2020) Vol. 15, Iss. 5, pp. 845-852
Open Access | Times Cited: 303
The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of “inflame-aging”
Gholam Hossein Meftahi, Zohreh Jangravi, Hedayat Sahraei, et al.
Inflammation Research (2020) Vol. 69, Iss. 9, pp. 825-839
Open Access | Times Cited: 275
Editorial: Nicotine and SARS-CoV-2: COVID-19 may be a disease of the nicotinic cholinergic system
Konstantinos Farsalinos, Raymond Niaura, Jacques Le Houezec, et al.
Toxicology Reports (2020) Vol. 7, pp. 658-663
Open Access | Times Cited: 251
The role of host genetics in the immune response to SARS‐CoV‐2 and COVID‐19 susceptibility and severity
Inna G. Ovsyannikova, Iana H. Haralambieva, Stephen N. Crooke, et al.
Immunological Reviews (2020) Vol. 296, Iss. 1, pp. 205-219
Open Access | Times Cited: 237
COVID-19 in Children: Where do we Stand?
Georgia Nikolopoulou, Helena C. Maltezou
Archives of Medical Research (2021) Vol. 53, Iss. 1, pp. 1-8
Open Access | Times Cited: 210
Will children reveal their secret? The coronavirus dilemma
Fabio Midulla, Luca Cristiani, Enrica Mancino
European Respiratory Journal (2020) Vol. 55, Iss. 6, pp. 2001617-2001617
Open Access | Times Cited: 166
Co-expression of SARS-CoV-2 entry genes in the superficial adult human conjunctival, limbal and corneal epithelium suggests an additional route of entry via the ocular surface
Joseph Collin, Rachel Queen, Darin Zerti, et al.
The Ocular Surface (2020) Vol. 19, pp. 190-200
Open Access | Times Cited: 136
SARS-CoV-2 in children: spectrum of disease, transmission and immunopathological underpinnings
Phoebe Williams, Annaleise R. Howard‐Jones, Peter Hsu, et al.
Pathology (2020) Vol. 52, Iss. 7, pp. 801-808
Open Access | Times Cited: 116
Smoking and COVID-19: Adding Fuel to the Flame
Vivek K. Kashyap, Anupam Dhasmana, Andrew E. Massey, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 18, pp. 6581-6581
Open Access | Times Cited: 101
Role of children in the transmission of the COVID-19 pandemic: a rapid scoping review
Luís Rajmil
BMJ Paediatrics Open (2020) Vol. 4, Iss. 1, pp. e000722-e000722
Open Access | Times Cited: 92
Why COVID-19 is less frequent and severe in children: a narrative review
Reza Sinaei, Sara Pezeshki, Saeedeh Parvaresh, et al.
World Journal of Pediatrics (2020) Vol. 17, Iss. 1, pp. 10-20
Open Access | Times Cited: 82
Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity
Maria Vono, Angela Huttner, Sylvain Lemeille, et al.
Cell Reports (2021) Vol. 37, Iss. 1, pp. 109773-109773
Open Access | Times Cited: 76
Development of child immunity in the context of COVID-19 pandemic
Małgorzata Kloc, Rafik M. Ghobrial, Ernest Kuchar, et al.
Clinical Immunology (2020) Vol. 217, pp. 108510-108510
Open Access | Times Cited: 69
Is Covid-19 Severity Associated With ACE2 Degradation?
Ugo Bastolla, Patrick Chambers, David Abia, et al.
Frontiers in Drug Discovery (2022) Vol. 1
Open Access | Times Cited: 39
First COVID‐19 lockdown resulted in most respiratory viruses disappearing among hospitalised children, with the exception of rhinoviruses
Raffaella Nenna, Luigi Matera, Alessandra Pierangeli, et al.
Acta Paediatrica (2022) Vol. 111, Iss. 7, pp. 1399-1403
Open Access | Times Cited: 37
An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic
Sumit Jamwal, Akash Gautam, John D. Elsworth, et al.
Life Sciences (2020) Vol. 257, pp. 118105-118105
Open Access | Times Cited: 68
Pathogenesis of COVID-19 from the Perspective of the Damage-Response Framework
Liise‐anne Pirofski, Arturo Casadevall
mBio (2020) Vol. 11, Iss. 4
Open Access | Times Cited: 67
<p>Coronavirus Disease 2019 (COVID-19) in Children: Prevalence, Diagnosis, Clinical Symptoms, and Treatment</p>
Hadi Zare‐Zardini, Hossein Soltaninejad, Farzad Ferdosian, et al.
International Journal of General Medicine (2020) Vol. Volume 13, pp. 477-482
Open Access | Times Cited: 65
A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children
Matteo Di Nardo, Grace van Leeuwen, Alessandra Loreti, et al.
Pediatric Research (2020) Vol. 89, Iss. 5, pp. 1101-1108
Open Access | Times Cited: 63
Is the COVID‐19 thrombotic catastrophe complement‐connected?
Edward M. Conway, Edward L.G. Pryzdial
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 11, pp. 2812-2822
Open Access | Times Cited: 63
Is Cross-Reactive Immunity Triggering COVID-19 Immunopathogenesis?
Alberto Beretta, Martin Cranage, Donato Zipeto
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 61
The Wide Spectrum of COVID-19 Clinical Presentation in Children
Nadia Nathan, Blandine Prévost, Chiara Siléo, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 9, pp. 2950-2950
Open Access | Times Cited: 60
An insertion unique to SARS-CoV-2 exhibits superantigenic character strengthened by recent mutations
Mary Hongying Cheng, She Zhang, Rebecca A. Porritt, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 58
Page 1 - Next Page

Scroll to top